Table 2 Treatment results of tumor

Pain relief time (month)

5.6 (3.4–8.5)

Serum CA-199 continuous decline time (month)

4.3 (3.0–8.1)

Serum amylopsin and lipase post-HIFU (U/L)

115.8 (56.7–210.2)/222.2 (76.9–417.4)

RECIST(6 months after treatment)

 PR (%)

43.7

 SD (%)

25.0

 PD (%)

31.3

The median overall survival (OS) time (month)

14 (8.0–15.5)

Incidences of adverse event (SIRC) (%)

12.5 (2/16)